On the heels of a 1-for-10 reverse stock split that could help get the firm listed for trading in the U.S., broad-pipelined MediciNova Inc. - which went public in Japan early last year - filed a shelf registration with the SEC for the sale of up to $100 million in shares. (BioWorld Today) Read More